Skip to main content
Top
Published in: Clinical and Translational Oncology 8/2010

01-08-2010 | Erratum

Erratum to: Current controversies in the management of breast cancer

Authors: Ignasi Tusquets, Laura García-Estévez, Encarna Adrover, Lourdes Calvo, Isabel Álvarez, Jesús García Mata, Yolanda Fernández, Mireia Margueli, Miquel Ángel Seguí, M. Muñoz, César Rodríguez, Álvaro Rodríguez Lescure, Ramon Colomer, Pere Gascón, Miguel Martín, Emilio Alba, Agusti Barnadas, Antonio Llombart, Joan Albanell, Ana Lluch

Published in: Clinical and Translational Oncology | Issue 8/2010

Login to get access
Metadata
Title
Erratum to: Current controversies in the management of breast cancer
Authors
Ignasi Tusquets
Laura García-Estévez
Encarna Adrover
Lourdes Calvo
Isabel Álvarez
Jesús García Mata
Yolanda Fernández
Mireia Margueli
Miquel Ángel Seguí
M. Muñoz
César Rodríguez
Álvaro Rodríguez Lescure
Ramon Colomer
Pere Gascón
Miguel Martín
Emilio Alba
Agusti Barnadas
Antonio Llombart
Joan Albanell
Ana Lluch
Publication date
01-08-2010
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 8/2010
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-010-0558-9

Other articles of this Issue 8/2010

Clinical and Translational Oncology 8/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine